Artículos por temáticas

Blood serum miRNA: non-invasive biomarkers for Alzheimer's disease

Geekiyanage H, Jicha GA, Nelson PT, Chan C.

Exp Neurol. 2012 Jun;235(2):491-6. doi: 10.1016/j.expneurol.2011.11.026. Epub 2011 Dec 1.

The early events of Alzheimer's disease pathology: from mitochondrial dysfunction to BDNF axonal transport deficits

Ye X, Tai W, Zhang D.

Neurobiol Aging. 2012 Jun;33(6):1122.e1-10. doi: 10.1016/j.neurobiolaging.2011.11.004. Epub 2011 Dec 31.

Association of SORL1 alleles with late-onset Alzheimer's disease. findings from the GIGAS_LOAD study and mega-analysis

Olgiati P, Politis A, Albani D, Rodilossi S, Polito L, Ateri E, Zisaki A, Piperi C, Liappas I, Stamouli E, Mailis A, Atti AR, Ferrari B, Morini V, Moretti F, Biella G, Forloni G, Papadimitriou GN, Ron

Curr Alzheimer Res. 2012 May;9(4):491-9. doi: 10.2174/156720512800492431.

Role of WWOX/WOX1 in Alzheimer's disease pathology and in cell death signaling

Teng CC, Yang YT, Chen YC, Kuo YM, Sze CI.

Front Biosci (Elite Ed). 2012 Jan 1;4(5):1951-65. doi: 10.2741/e516.

Using CSF biomarkers to replicate genetic associations in Alzheimer's disease

Schott JM; ADNI Investigators.

Neurobiol Aging. 2012 Jul;33(7):1486.e9-15. doi: 10.1016/j.neurobiolaging.2011.02.008. Epub 2011 Apr 3.

APP physiological and pathophysiological functions: insights from animal models

Guo Q, Wang Z, Li H, Wiese M, Zheng H.

Cell Res. 2012 Jan;22(1):78-89. doi: 10.1038/cr.2011.116. Epub 2011 Jul 19.

Alzheimer's disease camouflaged by histrionic personality disorder

Hellwig S, Dykierek P, Hellwig B, Zwernemann S, Meyer PT.

Neurocase. 2012 Feb;18(1):75-9. doi: 10.1080/13554794.2011.556125. Epub 2011 Sep 23.

Recent rodent models for Alzheimer's disease: clinical implications and basic research

Braidy N, Muñoz P, Palacios AG, Castellano-Gonzalez G, Inestrosa NC, Chung RS, Sachdev P, Guillemin GJ.

J Neural Transm (Vienna). 2012 Feb;119(2):173-95. doi: 10.1007/s00702-011-0731-5. Epub 2011 Nov 16.

Functional magnetic resonance imaging of semantic memory as a presymptomatic biomarker of Alzheimer's disease risk

Sugarman MA, Woodard JL, Nielson KA, Seidenberg M, Smith JC, Durgerian S, Rao SM.

Biochim Biophys Acta. 2012 Mar;1822(3):442-56. doi: 10.1016/j.bbadis.2011.09.016. Epub 2011 Oct 4.

Young Alzheimer patients show distinct regional changes of oscillatory brain dynamics

de Waal H, Stam CJ, de Haan W, van Straaten EC, Scheltens P, van der Flier WM.

Neurobiol Aging. 2012 May;33(5):1008.e25-31. doi: 10.1016/j.neurobiolaging.2011.10.013. Epub 2011 Nov 26.

Localized hippocampus measures are associated with Alzheimer pathology and cognition independent of total hippocampal volume

Carmichael O, Xie J, Fletcher E, Singh B, DeCarli C; Alzheimer's Disease Neuroimaging Initiative.

Neurobiol Aging. 2012 Jun;33(6):1124.e31-41. doi: 10.1016/j.neurobiolaging.2011.08.016. Epub 2011 Dec 14.

The effects of APOE-ε4 on the BOLD response

Trachtenberg AJ, Filippini N, Mackay CE.

Neurobiol Aging. 2012 Feb;33(2):323-34. doi: 10.1016/j.neurobiolaging.2010.03.009. Epub 2010 Apr 20.

Psychotropic drug effects on gene transcriptomics relevant to Alzheimer disease

Lauterbach EC.

Alzheimer Dis Assoc Disord. 2012 Jan-Mar;26(1):1-7. doi: 10.1097/WAD.0b013e318214b7d0.

Review: unchained maladie - a reassessment of the role of Ubb(+1) -capped polyubiquitin chains in Alzheimer's disease

Chadwick L, Gentle L, Strachan J, Layfield R.

Neuropathol Appl Neurobiol. 2012 Apr;38(2):118-31. doi: 10.1111/j.1365-2990.2011.01236.x.

Auditory delta event-related oscillatory responses are decreased in Alzheimer's disease

Yener GG, Güntekin B, Örken DN, Tülay E, Forta H, Başar E.

Behav Neurol. 2012;25(1):3-11. doi: 10.3233/BEN-2012-0344.